
Dr. Medha Barbhaiya graduated from Columbia University where she majored in the Biological Sciences. She received her medical degree from Weill Cornell Medical College, and completed her residency in internal medicine at New York Presbyterian-Weill Cornell Medical College. During her rheumatology fellowship at Brigham and Women's Hospital in Boston, Dr. Barbhaiya obtained a Master's in Public Health degree from the Harvard T.H. Chan School of Public Health. She also received a Distinguished Fellow Award from the American College of Rheumatology and a Scientist Development Award from the Rheumatology Research Foundation. After completing her rheumatology fellowship, Dr. Barbhaiya joined th...
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions.
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains.
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry').